HIV/AIDS Vaccine
Cleaved, trimeric HIV-1 envelope glycoprotein vaccine antigens have been produced
Published in AIDS Weekly, August 21st, 2006
According to a report recently published in Protein Expression and Purification, "Trimeric HIV-1 envelope glycoproteins (Env) are now being evaluated instead of monomeric gp120 as vaccine antigens because they mimic more closely the spikes expressed on the surface of virions. Thus, it can be argued that trimers have a more native structure than gp120, so might be superior at raising neutralizing antibodies."
"One approach to making Env...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-08-21)
More Articles from AIDS Weekly
- HIV/AIDS Drug Development
HIV-1 replication suppressed by arginine deiminase of Mycoplasma arginini - HIV/AIDS Epidemiology
HLA-B58s alleles have an impact on HIV-1 infection among native Africans - HIV/AIDS Long-Term Nonprogressors
Anti-CCR5 antibody induction may protect against HIV progression in long-term nonprogressors - HIV/AIDS Perinatal Transmission
Maternal autologous neutralizing antibody protective against perinatal HIV-1 transmission - HIV/AIDS Vaccine
Locally elicited immune responses at mucosal entry sites likely to favor immune activation - Anal Cancer
Anal carcinoma evaluated by FDG-PET/CT - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
